2 Unstoppable Stocks to Buy and Hold For at Least 10 Years

The stock market delivered a strong performance over the trailing-12-month period. That makes what Eli Lilly (NYSE: LLY) and Booking Holdings (NASDAQ: BKNG) have accomplished over this period even more impressive, as both companies easily crushed the S&P 500.

However, it’s not too late to buy either stock. Eli Lilly and Booking Holdings — although in very different industries — boast excellent prospects that should allow them to deliver market-beating returns through the next decade and beyond. Here’s the rundown.

1. Eli Lilly

Eli Lilly vowed to launch up to four new products on the market last year. The company was only able to reach half of that total in the U.S., as it encountered regulatory roadblocks for the other two. Most biotechs in this situation would have seen their shares drop, but not Eli Lilly. The company’s stock still significantly outperformed the broader market.

Here’s one big reason. Eli Lilly’s newly approved diabetes medicine, Mounjaro, is a game changer. It has a novel and unique mechanism of action among a sea of competitors in this field. Last year, it earned approval in treating obesity, a market where it will carry the brand name Zepbound. This medicine could hit peak annual sales of $25 billion, according to some analysts, and go on to become one of the best-selling medicines in the history of the industry.

If that seems too optimistic, consider that Mounjaro was first approved in May 2022, yet it generated nearly $3 billion in revenue through Sept. 30 of last year — and that was before its approval as an obesity treatment. There is no doubt that Mounjaro has an incredibly bright future.

It will have some help, too. Eli Lilly is awaiting approval from the U.S. Food and Drug Administration for donanemab, a potential Alzheimer’s disease treatment. The company’s other newer medicines will also be important, as will older ones, such as the cancer drug Verzenio.

What does all this mean for investors? Eli Lilly should record excellent financial…